Evaluation and associated risk factors for neutropenia with venetoclax and obinutuzumab in the treatment of chronic lymphocytic leukemia

por Samuels, Courtney, Abbott, Diana, Niemiec, Sierra, Tobin, Jennifer, Falco, Angela, Halsema, Keri, Kamdar, Manali
Publicado 2021

Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outc...

por Wagner, Charlotte B., Boucher, Ken, Nedved, Adrienne, Micallef, Ivana N., Desai, Sanjal, Hatic, Haris, Goyal, Gaurav, Zacholski, Erin, Fegley, Amanda, Sigmund, Audrey M., Bond, David A., Samuels, Courtney, Kamdar, Manali K., Aqeel, Sheeba Ba, Torka, Pallawi, MacDougall, Kira, Borogovac, Azra, Rajeeve, Sridevi, Sundaram, Suchitra, Fedak, Kalub, Modi, Dipenkumar, Travers, Elizabeth, Ayyappan, Sabarish, Chilakamarri, Nitin, Brem, Elizabeth A., Ermann, Daniel A., Fitzgerald, Lindsey A., Hu, Boyu, Stephens, Deborah M., Shah, Harsh
Publicado 2023